Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Total Non-Current Liabilities (2022 - 2023)

iBio (IBIO) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $24.2 million as the latest value for Q3 2023.

  • Quarterly Total Non-Current Liabilities changed N/A to $24.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $24.2 million through Sep 2023, changed N/A year-over-year, with the annual reading at $25.3 million for FY2023, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q3 2023 was $24.2 million at iBio, down from $25.3 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $31.9 million in Q4 2022, with the low at $24.2 million in Q3 2023.